Functional relevance of aromatic residues in the first transmembrane domain of P2X receptors
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't
Grant support
Z01 HD000195
Intramural NIH HHS - United States
PubMed
19425179
PubMed Central
PMC2727158
DOI
10.1111/j.1471-4159.2009.06021.x
Knihovny.cz E-resources
- MeSH
- Adenosine Triphosphate analogs & derivatives pharmacology MeSH
- Amino Acids, Aromatic genetics metabolism MeSH
- Biophysics MeSH
- Electric Stimulation MeSH
- Protein Conformation MeSH
- Humans MeSH
- Membrane Potentials drug effects genetics MeSH
- Patch-Clamp Techniques methods MeSH
- Mutagenesis genetics MeSH
- Receptors, Purinergic P2 classification genetics metabolism MeSH
- Amino Acid Sequence MeSH
- Signal Transduction drug effects physiology MeSH
- Protein Structure, Tertiary genetics physiology MeSH
- Transfection methods MeSH
- Cell Line, Transformed MeSH
- Protein Binding genetics physiology MeSH
- Dose-Response Relationship, Drug MeSH
- Green Fluorescent Proteins genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Intramural MeSH
- Names of Substances
- Adenosine Triphosphate MeSH
- alpha,beta-methyleneadenosine 5'-triphosphate MeSH Browser
- Amino Acids, Aromatic MeSH
- enhanced green fluorescent protein MeSH Browser
- Receptors, Purinergic P2 MeSH
- Green Fluorescent Proteins MeSH
The functional relevance of aromatic residues in the upper part of the transmembrane domain-1 of purinergic P2X receptors (P2XRs) was examined. Replacement of the conserved Tyr residue with Ala had a receptor-specific effect: the P2X1R was non-functional, the P2X2R, P2X4R, and P2X3R exhibited enhanced sensitivity to ATP and alphabeta-meATP accompanied by prolonged decay of current after washout of agonists, and the P2X7R sensitivity for agonists was not affected, though decay of current was delayed. The replacement of the P2X4R-Tyr42 with other amino acids revealed the relevance of an aromatic residue at this position. Mutation of the neighboring Phe and ipsilateral Tyr/Trp residues, but not the contralateral Phe residue, also affected the P2X2R, P2X3R, and P2X4R function. Double mutation of ipsilateral Tyr42 and Trp46 P2X4R residues restored receptor function, whereas the corresponding P2X2R double mutant was not functional. In contrast, mutation of the contralateral Phe48 residue in the P2X4R-Y42A mutant had no effect. These results indicate that aromatic residues in the upper part of TM1 play important roles in the three-dimensional structure of the P2XRs and that they are required not only for ion conductivity but also for specificity of agonist binding and/or channel gating.
See more in PubMed
Akabas MH, Stauffer DA, Xu M, Karlin A. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science. 1992;258:307–310. PubMed
Brake AJ, Wagenbach MJ, Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 1994;371:519–523. PubMed
Cao L, Young MT, Broomhead HE, Fountain SJ, North RA. Thr339-to-serine substitution in rat P2X2 receptor second transmembrane domain causes constitutive opening and indicates a gating role for Lys308. J Neurosci. 2007;27:12916–12923. PubMed PMC
Duckwitz W, Hausmann R, Aschrafi A, Schmalzing G. P2X5 subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate. J Biol Chem. 2006;281:39561–39572. PubMed
Egan TM, Khakh BS. Contribution of calcium ions to P2X channel responses. J Neurosci. 2004;24:3413–3420. PubMed PMC
Egan TM, Haines WR, Voigt MM. A domain contributing to the ion channel of ATP-gated P2X2 receptors identified by the substituted cysteine accessibility method. J Neurosci. 1998;18:2350–2359. PubMed PMC
Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 1997;18:2714–2723. PubMed
Haines WR, Migita K, Cox JA, Egan TM, Voigt MM. The first transmembrane domain of the P2X receptor subunit participates in the agonist-induced gating of the channel. J Biol Chem. 2001a;276:32793–32798. PubMed
Haines WR, Voigt MM, Migita K, Torres GE, Egan TM. On the contribution of the first transmembrane domain to whole-cell current through an ATP-gated ionotropic P2X receptor. J Neurosci. 2001b;21:5885–5892. PubMed PMC
Jelinkova I, Yan Z, Liang Z, Moonat S, Teisinger J, Stojilkovic SS, Zemkova H. Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun. 2006;349:619–625. PubMed
Jelinkova I, Vavra V, Jindrichova M, Obsil T, Zemkova HW, Zemkova H, Stojilkovic SS. Identification of P2X4 receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch. 2008;456:939–950. PubMed
Jiang LH, Rassendren F, Surprenant A, North RA. Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor. J Biol Chem. 2000;275:34190–34196. PubMed
Jiang LH, Rassendren F, Spelta V, Surprenant A, North RA. Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X2 receptor. J Biol Chem. 2001;276:14902–14908. PubMed
Jiang LH, Kim M, Spelta V, Bo X, Surprenant A, North RA. Subunit arrangement in P2X receptors. J Neurosci. 2003;23:8903–8910. PubMed PMC
Khakh BS, Egan TM. Contribution of transmembrane regions to ATP-gated P2X2 channel permeability dynamics. J Biol Chem. 2005;280:6118–6129. PubMed
Klapperstuck M, Buttner C, Schmalzing G, Markwardt F. Functional evidence of distinct ATP activation sites at the human P2X(7) receptor. J Physiol. 2001;534:25–35. PubMed PMC
Li M, Chang TH, Silberberg SD, Swartz KJ. Gating the pore of P2X receptor channels. Nat Neurosci. 2008 PubMed PMC
Li Z, Migita K, Samways DS, Voigt MM, Egan TM. Gain and loss of channel function by alanine substitutions in the transmembrane segments of the rat ATP-gated P2X2 receptor. J Neurosci. 2004;24:7378–7386. PubMed PMC
Lynch KJ, Touma E, Niforatos W, Kage KL, Burgard EC, van Biesen T, Kowaluk EA, Jarvis MF. Molecular and functional characterization of human P2X2 receptors. Mol Pharmacol. 1999;56:1171–1181. PubMed
Marquez-Klaka B, Rettinger J, Bhargava Y, Eisele T, Nicke A. Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X1 receptor. J Neurosci. 2007;27:1456–1466. PubMed PMC
Migita K, Haines WR, Voigt MM, Egan TM. Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X2 receptor. J Biol Chem. 2001;276:30934–30941. PubMed
Newbolt A, Stoop R, Virginio C, Surprenant A, North RA, Buell G, Rassendren F. Membrane topology of an ATP-gated ion channel (P2X receptor) J Biol Chem. 1998;273:15177–15182. PubMed
Nicke A, Baumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. Embo J. 1998;17:3016–3028. PubMed PMC
Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. Embo J. 2006;25:5071–5082. PubMed PMC
Priel A, Silberberg SD. Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol. 2004;123:281–293. PubMed PMC
Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413–492. PubMed
Rassendren F, Buell G, Newbolt A, North RA, Surprenant A. Identification of amino acid residues contributing to the pore of a P2X receptor. Embo J. 1997;16:3446–3454. PubMed PMC
Samways DS, Egan TM. Acidic amino acids impart enhanced Ca2+ permeability and flux in two members of the ATP-gated P2X receptor family. J Gen Physiol. 2007;129:245–256. PubMed PMC
Samways DS, Migita K, Li Z, Egan TM. On the role of the first transmembrane domain in cation permeability and flux of the ATP-gated P2X2 receptor. J Biol Chem. 2008;283:5110–5117. PubMed
Silberberg SD, Chang TH, Swartz KJ. Secondary structure and gating rearrangements of transmembrane segments in rat P2X4 receptor channels. J Gen Physiol. 2005;125:347–359. PubMed PMC
Silberberg SD, Li M, Swartz KJ. Ivermectin interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron. 2007;54:263–274. PubMed
Torres GE, Egan TM, Voigt MM. Topological analysis of the ATP-gated ionotropic [correction of ionotrophic P2X2 receptor subunit. FEBS Lett. 1998;425:19–23. PubMed
Torres GE, Egan TM, Voigt MM. Identification of a domain involved in ATP-gated ionotropic receptor subunit assembly. J Biol Chem. 1999;274:22359–22365. PubMed
Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature. 1994;371:516–519. PubMed
Vial C, Roberts JA, Evans RJ. Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol Sci. 2004;25:487–493. PubMed
Wilkinson WJ, Jiang LH, Surprenant A, North RA. Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor. Mol Pharmacol. 2006;70:1159–1163. PubMed
Yan Z, Liang Z, Tomic M, Obsil T, Stojilkovic SS. Molecular determinants of the agonist binding domain of a P2X receptor channel. Mol Pharmacol. 2005;67:1078–1088. PubMed
Yan Z, Li S, Liang Z, Tomic M, Stojilkovic SS. The P2X7 receptor channel pore dilates under physiological ion conditions. J Gen Physiol. 2008;132:563–573. PubMed PMC
Young MT, Pelegrin P, Surprenant A. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharmacol. 2007;71:92–100. PubMed
Allosteric regulation of the P2X4 receptor channel pore dilation